Open AccessSafety and effectiveness of reoperation for persistent or recurrent drug refractory secondary hyperparathyroidism
Author(s) -
Lei Zhu,
Feng Cheng,
Xi Zhu,
Bin Zhou,
Yonghong Xu,
Yong Wu,
Chuxiao Shao
Publication year - 2020
Publication title -
gland surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 22
eISSN - 2227-8575
pISSN - 2227-684X
DOI - 10.21037/gs-20-391
Subject(s) - medicine , secondary hyperparathyroidism , refractory (planetary science) , surgery , hypoparathyroidism , parathyroid hormone , parathyroid gland , hyperparathyroidism , urology , calcium , physics , astrobiology
Drug-refractory secondary hyperparathyroidism (SHPT) is the most common complication in patients with chronic renal failure (CRF). Although surgery is the most effective and safe method for drug-refractory SHPT, the condition may persist or recur after the primary surgery, and reoperation is often required in these patients. The purpose of our current study was to evaluate the safety and effectiveness of reoperation for drug-refractory SHPT.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom